Identification of coenzyme A-related tolmetin metabolites in rats: Relationship with reactive drug metabolites

Xenobiotica

Volumn 33, Issue 5, 2003, Pages 561-570

  Olsen, J ^a   Bjornsdottir I ^b   Honore Hansen S ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLIC ACID DERIVATIVE; CLOFIBRIC ACID; DRUG METABOLITE; GLUTATHIONE; NAPROXEN; TOLMETIN; TOLMETIN GLYCINE; TOLMETIN TAURINE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; DRUG EXCRETION; DRUG FECES LEVEL; DRUG IDENTIFICATION; DRUG STRUCTURE; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; INCUBATION TIME; MALE; MASS SPECTROMETRY; NONHUMAN; PROTEIN BINDING; RADIOACTIVITY; RAT; STRUCTURE ANALYSIS;

ACYL COENZYME A; ADMINISTRATION, ORAL; ANIMALS; CLOFIBRIC ACID; GLUTATHIONE; GLYCINE; MALE; NAPROXEN; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TAURINE; TOLMETIN; TRITIUM;

EID: 0037495951     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/0049825031000085942     Document Type: Article

References (27)

1. BAILEY, M. J. and DICKINSON, R. G., 1996, Chemical and immunochemical comparison of protein adduct formation of four carboxylate drugs in rat liver and plasma. Chemical Research in Toxicology, 9, 659-666.
2. BENET, L. Z., SPAHN-LANGGUTH, H., IWAKAWA, S., VOLLAND, C., MIZUMA, T., MAYER, S., MUTSCHLER, E. and LIN, E. T., 1993, Predictability of the covalent binding of acidic drugs in man. Life Sciences, 53, PL141-146.
3. BRUGGER, R., REICHEL, C., ALIA, B. G., BRUNE, K., YAMAMOTO, T., TEGEDER, I. and GEISSLINGER, G., 2001, Expression of rat liver long-chain acyl-CoA synthetase and characterization of its role in the metabolism of R-ibuprofen and other fatty acid-like xenobiotics. Biochemical Pharmacology, 61, 651-656.
4. GREGUS, Z., FEKETE, T., HALASZI, E., GYURASICS, A. and KLAASSEN, C. D., 1998, Effects of fibrates on the glycine conjugation of benzoic acid in rats. Drug Metabolism and Disposition, 26, 1082-1088.
5. GRILLO, M. P. and BENET, L. Z., 2002, Studies on the reactivity of clofibryl-S-acyl-CoA thioester with glutathione in vitro. Drug Metabolism and Disposition, 30, 55-62.
6. GRINDEL, J. M., 1981, The pharmacokinetic and metabolic profile of the antiinflammatory agent tolmetin in laboratory animals and man. Drug Metabolism Reviews, 12, 363-377.
7. HASHIMOTO, M., MIYAZAKI, H., NAMBU, K., FUJII, O., ARAKAWA, S., YOSHIDA, K. and UTSUI, Y., 1979, Studies on disposition and metabolism of tolmetin, a new anti-inflammatory agent, in rats and mice. Drug Metabolism and Disposition, 7, 20-23.
8. HUTT, A. J. and CALDWELL, J., 1990, Amino acid conjugation. In G. J. Mulder (ed.), Conjugation Reactions in Drug Metabolism (London: Taylor & Francis), pp. 273-304.
9. HYNECK, M. L., SMITH, P. C., MUNAFO, A., MCDONAGH, A. F. and BENET, L. Z., 1988, Disposition and irreversible plasma protein binding of tolmetin in humans. Clinical Pharmacology and Therapeutics, 44, 107-114.
10. HYNECK, M. L., SMITH, P. C., UNSELD, E. and BENET, L. Z., 1987, HPLC determinations of tolmetin, tolmetin glucuronide and its isomeric conjugates in plasma and urine. Journal of Chromatography, 420, 349-356.
11. IWAKI, M., OGISO, T., INAGAWA, S. and KAKEHI, K., 1999, In vitro regioselective stability of β-1-O- and 2-O-acyl glucuronides of naproxen and their covalent binding to human serum albumin. Journal of Pharmaceutical Sciences, 88, 52-57.
12. KAWAGUCHI, A., YOSHIMURA, T. and OKUDA, S., 1981, A new method for the preparation of acyl-CoA thioesters. Journal of Biochemistry, 89, 337-339.
13. KING, A. R. and DICKINSON, R. G., 1996, The utility of the bile-exteriorized rat as a source of reactive acyl glucuronide: studies with zomepirac. Journal of Pharmacological and Toxicological Methods, 36, 131-136.
14. KNIGHTS, K. M, 1998, Role of hepatic fatty acid:coenzyme A ligases in the metabolism of xenobiotic carboxylic acids. Clinical and Experimental Pharmacology and Physiology, 25, 776-782.
15. MATHEWS, C. K. and VAN HOLDE, K. E., 1990, Biochemistry (Redwood City: Benjamin Cummings).
16. MELEGH, B., KERNER, J., JASZAI, V. and BIEBER, L. L., 1990, Differential excretion of xenobiotic acylesters of carnitine due to administration of pivampicillin and valproate. Biochemical Medicine and Metabolic Biology, 43, 30-38.
17. OLSEN, J., BJØRNSDOTTIR, I., TJØRNELUND, J. and HANSEN, S. H., 2002, Chemical reactivity of the naproxen acyl glucuronide and the naproxen coenzyme A thioester towards bionucleophiles. Journal of Pharmaceutical and Biomedical Analysis, 29, 7-15.
18. QIU, Y., BENET, L. Z. and BURLINGAME, A. L., 1998, Identification of the hepatic protein targets of reactive metabolites of acetaminophen in vivo in mice using two-dimensional gel electrophoresis and mass spectrometry. Journal of Biological Chemistry, 273, 17940-17953.
19. QIU, Y., BENET, L. Z. and BURLINGAME, A. L., 2001, Identification of hepatic protein targets of the reactive metabolites of the non-hepatotoxic regioisomer of acetaminophen, 3′-hydroxyacetanilide, in the mouse in vivo using two-dimensional gel electrophoresis and mass spectrometry. Advances in Experimental Medicine and Biology, 500, 663-673.
20. SALLUSTIO, B. C., NUNTHASOMBOON, S., DROGEMULLER, C. J. and KNIGHTS, K. M., 2000, In vitro covalent binding of nafenopin-CoA to human liver proteins. Toxicology and Applied Pharmacology, 163, 176-182.
21. SHORE, L. J., FENSELAU, C., KING, A. R. and DICKINSON, R. G., 1995, Characterization and formation of the glutathione conjugate of clofibric acid. Drug Metabolism and Disposition, 23, 119-123.
22. SMITH, P. C., MCDONAGH, A. F. and BENET, L. Z., 1986, Irreversible binding of zomiperac to plasma protein in vitro and in vivo. Journal of Clinical Investigations, 77, 934-939.
23. TRACY, T. S. and HALL, S. D., 1991, Determination of the epimeric composition of ibuprofenyl-CoA. Analytical Biochemistry, 195, 24-29.
24. WANG, M. and DICKINSON, R. G., 2000, Bile duct ligation promotes covalent drug-protein adduct formation in plasma but not in liver of rats given zomepirac. Life Sciences, 68, 525-537.
25. ZIA-AMIRHOSSEINI, P., HARRIS, R. Z., BRODSKY, F. M. and BENET, L. Z., 1995, Hypersensitivity to nonsteroidal anti-inflammatory drugs. Nature Medicine, 1, 2-4.
26. ZIA-AMIRHOSSEINI, P., OJINGWA, J. C., SPAHN-LANGGUTH, H., MCDONAGH, A. F. and BENET, L. Z., 1994, Enhanced covalent binding of tolmetin to proteins in humans after multiple dosing. Clinical Pharmacology and Therapeutics, 55, 21-27.
27. ZIMMERMAN, H. J., 1994, Hepatic injury associated with nonsteroidal anti-inflammatory drugs. In A. J. Lewis and D. E. Furst (eds), Non-Steroidal Anti-Inflammatory Drugs: Mechanisms and Clinical Uses (New York: Marcel Dekker), pp. 171-194.